Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
biote Corp (NASDAQ: BTMD) closed the day trading at $3.07 down -25.12% from the previous closing price of $4.10. In other words, the price has decreased by -$25.12 from its previous closing price. On the day, 1.6 million shares were traded. BTMD stock price reached its highest trading level at $3.71 during the session, while it also had its lowest trading level at $3.04.
Ratios:
For a better understanding of BTMD, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.24 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.21. For the most recent quarter (mrq), Quick Ratio is recorded 1.03 and its Current Ratio is at 1.32.
On February 20, 2024, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $9.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 09 ’24 when Peterson Robert Charles sold 32,874 shares for $6.20 per share. The transaction valued at 203,848 led to the insider holds 0 shares of the business.
Peterson Robert Charles sold 11,376 shares of BTMD for $86,084 on Jul 09 ’24. The Chief Financial Officer now owns 32,874 shares after completing the transaction at $7.57 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BTMD now has a Market Capitalization of 161941264 and an Enterprise Value of 171282800. As of this moment, biote’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.05, and their Forward P/E ratio for the next fiscal year is 5.96. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.17. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.85. Its current Enterprise Value per Revenue stands at 0.869 whereas that against EBITDA is 4.868.
Stock Price History:
The Beta on a monthly basis for BTMD is 1.06, which has changed by -0.5557164 over the last 52 weeks, in comparison to a change of 0.07903516 over the same period for the S&P500. Over the past 52 weeks, BTMD has reached a high of $8.44, while it has fallen to a 52-week low of $4.03. The 50-Day Moving Average of the stock is -39.17%, while the 200-Day Moving Average is calculated to be -48.91%.
Shares Statistics:
Over the past 3-months, BTMD traded about 138.02K shares per day on average, while over the past 10 days, BTMD traded about 293670 shares per day. A total of 32.70M shares are outstanding, with a floating share count of 30.04M. Insiders hold about 8.13% of the company’s shares, while institutions hold 70.41% stake in the company. Shares short for BTMD as of 1740700800 were 651439 with a Short Ratio of 4.72, compared to 1738281600 on 703217. Therefore, it implies a Short% of Shares Outstanding of 651439 and a Short% of Float of 3.05.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The dynamic stock of biote Corp (BTMD) is currently being evaluated by a team of 1.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is $0.16, with high estimates of $0.16 and low estimates of $0.16.
Analysts are recommending an EPS of between $0.93 and $0.93 for the fiscal current year, implying an average EPS of $0.93. EPS for the following year is $1.31, with 1.0 analysts recommending between $1.31 and $1.31.
Revenue Estimates
4 analysts predict $47.25M in revenue for the current quarter. It ranges from a high estimate of $47.76M to a low estimate of $46.84M. As of the current estimate, biote Corp’s year-ago sales were $46.8MFor the next quarter, 4 analysts are estimating revenue of $50.55M. There is a high estimate of $51.41M for the next quarter, whereas the lowest estimate is $50.13M.
A total of 6 analysts have provided revenue estimates for BTMD’s current fiscal year. The highest revenue estimate was $237.8M, while the lowest revenue estimate was $202.54M, resulting in an average revenue estimate of $213.29M. In the same quarter a year ago, actual revenue was $197.19MBased on 5 analysts’ estimates, the company’s revenue will be $233.79M in the next fiscal year. The high estimate is $281.6M and the low estimate is $217.8M.
